PipelineReview.com10h
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
LAUSANNE, Switzerland I 17, 2024 I AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for ...
PipelineReview.com13h
MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus
COPENHAGEN, Denmark and MUNICH, Germany I September 17, 2024 I MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic ...
PipelineReview.com13h
Mindpeak Announces Collaboration With Roche to Enhance Cancer Diagnostics Through AI
HAMBURG, Germany I 16, 2024 I Mindpeak announces its collaboration with Roche that will integrate Mindpeak's innovative AI algorithm with Roche’s ...
PipelineReview.com13h
WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024
BARCELONA, Spain I 16, 2024 I WestGene Biopharma, a leading innovator in mRNA therapeutics, presented the latest clinical data for its EBV-positive ...